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Résumé en
anglais
Multiple pathophysiological mechanisms have been proposed to contribute to the
increased cardiovascular morbidity in obstructive sleep apnoea (OSA), including
autonomic dysfunction, inflammation, oxidative stress and endothelial dysfunction 1.
Microparticles (MPs) are small membrane vesicles that are shed from circulating
cells or from the components of the vessel wall in response to activation and
apoptosis. There is growing evidence in support of a potential role of MPs in the
field of cardiovascular diseases. Increased levels of MPs derived from various cell
types are found in patients at risk of cardiovascular diseases 2. By modulating
inflammation, coagulation, vasomotor reactivity and angiogenesis, MPs might
directly contribute to cardiovascular diseases 2. Recent case–control studies suggest
a potential involvement of MPs in OSA-associated cardiovascular morbidity 3–6. An
increase in morning levels of MPs derived from activated leukocytes has been
demonstrated in otherwise healthy male OSA patients with marked nocturnal
desaturations 5. In vitro, nitric oxide (NO) production by endothelial cells incubated
with MPs from OSA patients correlates negatively with circulating levels of activated
leukocyte-derived MPs 5. Ex vivo, mice previously injected with MPs from OSA
patients display endothelial dysfunction, reduced endothelial NO release and
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